-
1
المؤلفون: Simona Granata, Giovanni Stallone, Pierluigi Carratù, Gianluigi Zaza
المصدر: Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacologyمصطلحات موضوعية: Oncology, medicine.medical_specialty, Pulmonary toxicity, Mini Review, medicine.medical_treatment, kidney transplantation, RM1-950, Diabetes mellitus, Internal medicine, Pulmonary fibrosis, mTOR-inhibitors, medicine, Pharmacology (medical), Kidney transplantation, Pharmacology, Everolimus, pulmonary fibrosis, SARS-CoV-2, business.industry, COVID-19, Immunosuppression, everolimus, medicine.disease, sirolimus, Sirolimus, Therapeutics. Pharmacology, Cytokine storm, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce7c0b0afb17da39361534580db39b13Test
https://doi.org/10.3389/fphar.2021.710543Test -
2
المصدر: Frontiers in Pharmacology, Vol 11 (2020)
Frontiers in Pharmacology, 11
Frontiers in Pharmacology
Schoot, T S, Kerckhoffs, A P M, Hilbrands, L B & van Marum, R J 2020, ' Immunosuppressive Drugs and COVID-19: A Review ', Frontiers in Pharmacology, vol. 11, 1333 . https://doi.org/10.3389/fphar.2020.01333Testمصطلحات موضوعية: 0301 basic medicine, mTOR inhibitors, ARDS, Middle East respiratory syndrome coronavirus, viruses, coronavirus, immunosuppressive drugs, Review, medicine.disease_cause, corticosteroids, law.invention, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Tocilizumab, Randomized controlled trial, law, medicine, Pharmacology (medical), Coronavirus, Pharmacology, Thiopurine methyltransferase, biology, SARS-CoV-2, business.industry, lcsh:RM1-950, COVID-19, virus diseases, medicine.disease, calcineurin inhibitors, Clinical trial, lcsh:Therapeutics. Pharmacology, 030104 developmental biology, chemistry, 030220 oncology & carcinogenesis, Immunology, biology.protein, Renal disorders Radboud Institute for Health Sciences [Radboudumc 11], Cytokine storm, business, mycophenolic acid
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe79b72c24b0376057e039c11926680dTest
https://doi.org/10.3389/fphar.2020.01333Test -
3
المؤلفون: Maurizio Renna
المساهمون: Apollo - University of Cambridge Repository, Renna, Maurizio
المصدر: Frontiers in Pharmacology
مصطلحات موضوعية: 0301 basic medicine, mTOR inhibitors, mTOR inhibitor, drug design, Drug Resistance, resistance mechanisms, Biology, Genome, Mice, 03 medical and health sciences, chemistry.chemical_compound, cancer therapeutics, Resistance mechanism, 0302 clinical medicine, Cell Line, Tumor, Neoplasms, Animals, Humans, Pharmacology (medical), Phosphatidylinositol, Protein Kinase Inhibitors, PI3K/AKT/mTOR pathway, Pharmacology, Binding Sites, Cellular metabolism, General Commentary, Kinase, TOR Serine-Threonine Kinases, RPTOR, Discovery and development of mTOR inhibitors, Xenograft Model Antitumor Assays, Cancer therapeutic, Protein Structure, Tertiary, 3. Good health, Cell biology, 030104 developmental biology, mTOR pathway, chemistry, 030220 oncology & carcinogenesis, Mutation, Female, Human cancer, Signal Transduction
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::165ecfc47f8b660de0afb002960edecdTest